Articles with "factor inhibitor" as a keyword



Photo by charlesdeluvio from unsplash

Pipiserpin, a Culex Factor Xa inhibitor, affects female reproductive capacity and serve as a potential target for mosquito control.

Sign Up to like & get
recommendations!
Published in 2022 at "Pest management science"

DOI: 10.1002/ps.6984

Abstract: BACKGROUND Mosquito control is still the main prevention and control measure of numerous mosquito-borne diseases causing millions of deaths each year. New strategies for mosquito control are in demand. Proteases play an important role in… read more here.

Keywords: factor inhibitor; control; pipiserpin; mosquito control ... See more keywords
Photo by schluditsch from unsplash

Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of medical economics"

DOI: 10.1080/13696998.2022.2042106

Abstract: AIMS To conduct a cost-effectiveness analysis (CEA) on the use of andexanet alfa for the treatment of factor Xa inhibitor-related intracranial hemorrhage (ICH) from the United States (US) third-party payer and societal perspectives. METHODS CEA… read more here.

Keywords: cost; treatment; factor inhibitor; factor ... See more keywords
Photo by chrostek from unsplash

MO126CLINICAL AND BIOMARKER CHARACTERISTICS OF PATIENTS WITH C3G OR IC-MPGN ENROLLED IN TWO PHASE II STUDIES INVESTIGATING THE FACTOR D INHIBITOR DANICOPAN*

Sign Up to like & get
recommendations!
Published in 2021 at "Nephrology Dialysis Transplantation"

DOI: 10.1093/ndt/gfab092.004

Abstract: C3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN) are rare, progressive kidney diseases requiring a biopsy for definite diagnosis. Both C3G and IC-MPGN are attributed to complement dysregulation, with dysregulation of the alternative pathway… read more here.

Keywords: biomarker; c3g mpgn; factor inhibitor; characteristics patients ... See more keywords
Photo from wikipedia

Measurement of pre‐treatment inflammatory cytokine levels is valuable for prediction of treatment efficacy to tumor necrosis factor inhibitor in axial spondyloarthritis patients

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Rheumatic Diseases"

DOI: 10.1111/1756-185x.14353

Abstract: To evaluate the correlation of inflammatory cytokines with the treatment response to tumor necrosis factor inhibitor (TNFi) in axial spondyloarthritis (axSpA) patients. read more here.

Keywords: necrosis factor; axial spondyloarthritis; tumor necrosis; treatment ... See more keywords
Photo from wikipedia

Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two‐centre, retrospective, cohort study

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Clinical Pharmacy and Therapeutics"

DOI: 10.1111/jcpt.13771

Abstract: Immune disorder is a key trigger of recurrent spontaneous abortion (RSA); meanwhile, tumour necrosis factor inhibitor (TNFi) is a fundamental therapeutic for multiple immune and inflammatory diseases. Hence, this real‐world study aimed to explore the… read more here.

Keywords: necrosis factor; combined intravenous; spontaneous abortion; recurrent spontaneous ... See more keywords
Photo from wikipedia

Tumor necrosis factor-α inhibitor-induced follicular psoriasiform eruption.

Sign Up to like & get
recommendations!
Published in 2022 at "Pediatric dermatology"

DOI: 10.1111/pde.14993

Abstract: Tumor necrosis factor-α inhibitor-associated adverse cutaneous reactions are common in patients with inflammatory bowel disease. Infection-related dermatoses and psoriasiform eruptions are seen most frequently. We describe a follicular psoriasiform eruption that appeared during treatment with… read more here.

Keywords: necrosis factor; factor inhibitor; tumor necrosis; follicular psoriasiform ... See more keywords
Photo from wikipedia

Prevention of Stent Thrombosis in Rats by a Direct Oral Factor Xa Inhibitor Edoxaban

Sign Up to like & get
recommendations!
Published in 2018 at "Pharmacology"

DOI: 10.1159/000494059

Abstract: Background/Aims: Stent thrombosis is a serious complication after percutaneous coronary intervention and femoropopliteal endovascular intervention. The aim of this study was to determine the antithrombotic effects of a direct factor Xa inhibitor edoxaban alone or… read more here.

Keywords: prevention stent; factor inhibitor; stent thrombosis; thrombosis ... See more keywords